Analytical testing of medical and combination devices ensures product performance and regulatory compliance.
As medical and combination product prototypes are developed, analytical methods are required to provide loading with the necessary amount of drug. The drug must have the desired stability and release kinetics to allow for appropriate delivery and clinical evaluation.
Testing may include drug assays, degradation product identification and identification/quantification of extractables and leachables for product approval. Also including optimization of drug elution rates from combination devices improves device efficacy.
Exova’s analytical testing experience related to medical and combination devices is extensive and enables us to assist you with method development, method validations, and lot release testing. Our analytical specialists have the expertise and experience to get your product through a comprehensive testing program, shortening the certification process and getting your product to market much quicker.
Specifically, we test for:
- Drug assays
- Drug elution rates
- Degradation product identification
- Residual chemicals (e.g. solvents and catalysts)
- Extractables and leachables
- Trace heavy metal content
With a strong track record of Good Manufacturing Practice (GMP), Exova’s laboratories are committed to delivering pharmaceutical testing services with the highest level of quality and control. Additionally, we are inspected on a regular basis by the Food and Drug Administration (FDA) and Health Canada. This ensures the highest quality and safety of your product.
Contact UsWhatever your query, we'll pass it on to our experts and respond within a very short space of time.More details
Dubai Investments Park 1,
The Green Community,
P.O. Box: 34924,
Contact: Jason Dodds - Managing Director
Tel: +971 4 885 1001
Fax: +971 4 885 4004